Libya’s Bashagha to Asharq Al-Awsat: I Will Remain in My Post Until Elections Are Held

Head of Libya’s government of stability, Fathi Bashagha. (Reuters)
Head of Libya’s government of stability, Fathi Bashagha. (Reuters)
TT

Libya’s Bashagha to Asharq Al-Awsat: I Will Remain in My Post Until Elections Are Held

Head of Libya’s government of stability, Fathi Bashagha. (Reuters)
Head of Libya’s government of stability, Fathi Bashagha. (Reuters)

Head of Libya’s government of stability, Fathi Bashagha announced that he would remain in his position until “all Libyan parties” agree on electoral laws, which are welcomed by the international community, and until they set dates for the presidential and parliamentary elections.

“Only then will I decide,” he told Asharq Al-Awsat in an interview.

On whether he will run for president, he said he will make up his mind after the laws and regulations related to the polls are approved.

He hoped that the international community would take more steps in supporting the initiative of United Nations envoy Abdoulaye Bathily that aims for the elections to be held this year.

Bashagha dismissed claims that he has low chances of being elected president due to his government’s failure in entering the capital Tripoli to perform its duties.

“I have great popularity, whether I succeeded in entering Tripoli or not,” he stressed.

“Everyone knows that my project calls for the establishment of the state and this has prevented others from remaining in their posts for as long as possible and led to more calls for the elections to be held,” he remarked.

Commenting on his relations with Türkiye and reports that it had supplied his rival, head of the Government of National Unity (GNU) Abdulhamid al-Dbeibah, with drones to thwart his entry into Tripoli, Bashagha said: “Every phase has its circumstances and conditions. My relations with Ankara have been and continue to be excellent.”

Moreover, he praised the relations he enjoys with parliament Speaker Aguila Saleh. “Some believe that these ties are strained, but that is not true,” he added.

On reports that Libyan parties want to keep Seif al-Islam al-Gaddafi, the son of late ruler Moammar, from running in the presidential elections, Bashagha said the issue is always brought up when talks are held over dropping the candidacy of figures who have judicial rulings against them.

Seif al-Islam is instantly the target of such discussions, he noted, saying that such a judicial condition is part of electoral laws in several countries.

Turning to armed groups in Libya, he said the issue is “not impossible to resolve”.

“With enough international support and political will, the problem can be overcome,” he added.

Furthermore, he said that when he served as interior minister, he had come up with a training and rehabilitation program for the fighters. Several of them have already been recruited and others have graduated as officers.

The program, however, came to a halt after his term as minister ended.

In addition, he warned of the spread of illegal weapons in Libya. This makes the country a safe haven for extremists.

Terrorist cells are already present in the South, he noted. They may expand their activities if they receive the necessary funding, he warned.

These cells are involved in drug smuggling and human trafficking.

He underscored the importance of forming a southern border force that could address the security situation there.

However, the security institutions would continue to be weak in the absence of a united government and the continued divisions, he lamented.

Asked about the international efforts to support the UN initiative on Libya, Bashagha called for employing “any efforts to help resolve the crisis.”

He acknowledged that the United States and Europe are keen on the withdrawal of Russia’s Wagner group from Libya.

“That is not their only concern,” he remarked.

“The stability of Libya is their priority as it is for neighboring countries, like Egypt, Tunisia, Algeria and Sudan, and the rest of Africa,” he stressed.

“Everyone knows that the longer the crisis in Libya goes on, the more likely it is to impact Africa,” he warned.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.